Cardiology

New findings show patients were able to more than halve type 2 diabetes medication while improving diabetic and cardiovascular parameters in 8 weeks.

Data show no evidence of increased risk of adverse events in patients aged ≥80 years, compared to patients aged 70 - 79 years.

The study author joins to highlight new ADA 2021 findings showing rivaroxaban's benefit for a subpopulation of diabetic patients.

A prespecified analysis of DAPA-CKD presented at ADA 2021 suggests use of dapagliflozin reduced the incidence of type 2 diabetes by nearly 40% among patients with chronic kidney disease but without diabetes within the phase 3 trial.

Data from an analysis of FIDELIO-DKD suggests the renoprotective benefits of finerenone were consistent irrespective of SGLT2 inhibitor use and those using an SGLT2 inhibitor with finerenone resulted in greater UACR reductions.

New data show liraglutide reduced visceral, ectopic fat, with greater effects seen compared to weight loss.

A review of available data suggests patients with nephrotic syndrome were at a 19-fold greater risk of end-stage kidney disease and a 3-fold greater risk of acute coronary syndrome events.

Data from HIV POST SCD details the incidence rate of sudden cardiac death among HIV-positive persons compared to the general population.

Using 24 years of follow-up data from more than 12k adolescents provides insight into the impact of childhood BMI z-scores on risk of adverse health outcomes, including development of diabetes and premature myocardial infarction, in adulthood.

Study data show AF developed in 3745 patients, at an incidence rate of 15.3 per 1000 person-years.

Using data from within NHANES from 2011-2018, investigators from Johns Hopkins University provide a comprehensive overview of the use of aspirin for primary and secondary prevention among older patients based on diabetes status.

The FDA has granted approval to dabigatran etexilate (Pradaxa) for treatment of blood clots in pediatric patients with VTE and prevention of recurrent blood clots in those who have completed treatment for VTE.

Dabigatran etexilate was approved in both oral pellet and capsule forms for varying pediatric patient populations.

A pilot trial in 29 women suggests a combination of metformin and high dose fish oil could reduce triglycerides and ApoB-remnants among young women with polycystic ovary syndrome.

Data from more than 1000 women in Australia suggests each incremental increase in abdominal aortic calcification was linked to a 3% increase in the risk of fall-related hospitalizations.

Investigators considered myocarditis favorable to COVID-19 infection, with resolution of symptoms in all patients.

A case series of 7 patients from a pair of US medical centers details the treatment and presentation of patients with myocarditis-like illness after receiving a COVID-19 vaccine.

Results of an open-label randomized trial suggests targeted hypothermia among unconscious cardiac arrest patients may not provide mortality benefits compared to normothermic patients.

Our latest case report from Dr. Brady Pregerson features a man in his late 50s presenting to the ED for syncope. Check out the EKG and see if you can determine the correct diagnosis.

A comparison of data from patients with cancer and ASCVD from a nationally representative survey suggests the financial burden of cardiovascular disease was similar to or exceeded the burden imposed by cancer.

Data show higher risk for incident cancer observed with PCE of <7.2%, while higher PCE led to increased risk of incident CVD.

New research indicates improvements in cardiovascular health during young adulthood among patients with low baseline cardiovascular health could reduce the rates of premature cardiovascular disease as the population ages.

Data show variations in the type, effectiveness, and implementation of QI strategies for patients with CVD.

Data from the UK Biobank cohort details the increased risk of adverse health outcomes, including the development of diabetes and heart failure, among patients considered to have metabolically healthy obesity.